1. Home
  2. MNDO vs ALLR Comparison

MNDO vs ALLR Comparison

Compare MNDO & ALLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MIND C.T.I. Ltd.

MNDO

MIND C.T.I. Ltd.

HOLD

Current Price

$1.06

Market Cap

21.2M

Sector

Technology

ML Signal

HOLD

Logo Allarity Therapeutics Inc.

ALLR

Allarity Therapeutics Inc.

HOLD

Current Price

$1.27

Market Cap

19.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNDO
ALLR
Founded
1995
2004
Country
Israel
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.2M
19.3M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
MNDO
ALLR
Price
$1.06
$1.27
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$9.75
AVG Volume (30 Days)
34.3K
123.2K
Earning Date
05-08-2026
05-15-2026
Dividend Yield
20.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$320,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$8.57
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.98
$0.77
52 Week High
$1.68
$2.35

Technical Indicators

Market Signals
Indicator
MNDO
ALLR
Relative Strength Index (RSI) 38.22 52.06
Support Level $1.03 $1.01
Resistance Level $1.23 $1.29
Average True Range (ATR) 0.04 0.07
MACD 0.00 -0.01
Stochastic Oscillator 28.57 40.23

Price Performance

Historical Comparison
MNDO
ALLR

About MNDO MIND C.T.I. Ltd.

MIND C.T.I. Ltd develops, manufactures, markets, and implements real-time and off-line convergent billing and customer care software solutions. It derives revenue from the sale of software products and services in two reportable segments, namely Billing and Related Services, which derives key revenue, and Messaging. The company has three product lines: Product Line A- billing and customer care solutions for service providers; Product Line B - call accounting and call management solutions for enterprises; and Product Line C - mobile messaging, communication, and payment solutions. Geographically, the company operates in the Americas, Europe, Asia Pacific and Africa, and Israel. It earns maximum revenue from Europe.

About ALLR Allarity Therapeutics Inc.

Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.

Share on Social Networks: